• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Protagonist Therapeutics

An open book with pages turning on a wooden table set
Biotech

J&J eyes takeover of immunology partner Protagonist: WSJ

Protagonist's share price soared on reports that longtime partner J&J is in talks of a buyout.
Zoey Becker Oct 10, 2025 2:30pm
crown royalty king queen win

J&J's IL-23 drug defeats Sotyktu in phase 3 psoriasis trial

Sep 17, 2025 9:45am
bubbles on a pink background

At ASCO, execs see chance to ‘rewrite textbooks’ in cancer care

Jun 2, 2025 9:45am
scrabble tiles spelling out psoriasis

J&J, Protagonist's oral psoriasis prospect bests BMS' Sotyktu

Mar 10, 2025 7:30am
Graphic of a drop of blood made up of small data points and nodes

Takeda's $300M bet on Protagonist's blood cancer drug pays off

Mar 3, 2025 8:45am
On target clinical trial success bullseye score

J&J, Protagonist's oral psoriasis prospect scores in phase 3s

Nov 19, 2024 11:44am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings